1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Johnson & Johnson Innovation

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Type

Private Equity Firm (Investor)

Location

New Brunswick NJ US

Alternative Asset Classes

PE

Established

1973

Firm Ownership

Captive Arm – Corporate

Investment Team Staff

Total Staff

15
Johnson & Johnson Innovation (JJDC) is the venture capital subsidiary of Johnson & Johnson. JJDC makes private equity investments in venture funded health care companies and focuses mainly on industries such as medical devices, diagnostics, pharmaceuticals, biotechnology, consumer products, and wellness and prevention. The firm makes all stages of venture capital investments, and the size of the investment will depend on the stage the portfolio company has reached.
Asset Class No. of Funds Currently Managed Funds Raised in Last 10 Years Est. Dry Powder Strategies
Private Equity - Early Stage, Early Stage: Seed, Early Stage: Start-up, Expansion / Late Stage, Growth, Venture (General)
Real Estate - -
Private Debt - -
Infrastructure - -
Natural Resources - -
Asset Class No. of Funds Currently Managed AuM Date of AuM Strategies
Hedge Funds 0 -

Want to see more?

Request a demo for full access to this profile.

39 Known Decision Makers

Contact Name Position Location Email Telephone Asset Class
Principal, Venture Investments Shanghai, China PE VC
Principal, Venture Investments Petah Tikva, Israel PE VC
Head of JLABS San Diego, US PE VC
Principal, Venture Investments PE VC
Director, Early Innovation Partnering Menlo Park, US PE VC

Showing 5 of 39 known decision makers at Johnson & Johnson Innovation

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a Demo to see more

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.